AzTrials
AzTrials

Spastic Hemiplegic Cerebral PalsyNCT07733570

Effects of Sensory Integration Therapy in Children With Spastic Hemiplegic Cerebral Palsy

A study testing Sensory Integration Therapy and Conventional Physical Therapy in people with Spastic Hemiplegic Cerebral Palsy, run by Riphah International University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The Goal of this Clinical Trial is to learn if a treatmnet called Sensory Integration Therapy (SIT) can Improve walking,Balance and movemnet in children with a type of cerebral palsy called spastic hemiplegic Cerebral Palsy .This Condition affects one side of body and make walking uneven.The study will include… Read more about this study

Who is it for?
Ages 5 to 12 years
Conditions the study is for
Spastic Hemiplegic Cerebral Palsy
What is being tested?
Sensory Integration Therapy and Conventional Physical Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
22 Aug 2026to 20 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 5-12 years diagnosed with spastic hemiplegic CP
  • GMFCS level I-III
  • able to follow simple commands

Who cannot join

  • Severe cognitive impairment
  • recent orthopedic surgery
  • uncontrolled seizures.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Sidra Ghias Dr.Sidra Ghias, Phd* contact

03224356227

sidra.ghias@riphah.edu.pk

About this study

Official title: Effects of Sensory Integration Therapy on Functional Mobility ,Balance and Gait Symmetry in Children With Spastic Hemiplegic CP :A Randomized Trial

The Goal of this Clinical Trial is to learn if a treatmnet called Sensory Integration Therapy (SIT) can Improve walking,Balance and movemnet in children with a type of cerebral palsy called spastic hemiplegic Cerebral Palsy .This Condition affects one side of body and make walking uneven.The study will include children between 5-12 year old .

The main Question this study aims to answer are :

Read more

Does adding SIT to regular physical therapy improve How symmetrically children walk? Does adding SIT to regular physical therapy improve balance and daily movements skills,compared with regular/conventional Physical Therapy Alone.

Researches will compare two group of children to see if SIT + Conventional Physical Therapy work better then Convential Physical therapy alone .

Participant will be palaced into one of two groups by chance one group will recieive SIT alone with COnventional PT,the other group will recieve Conventional Therapy Alone only.

Attend Therapy session 3 time a week for 8 week Be tested before and after the 8 week using simple movement and balence tests,including a walking assessment done By video .

Read the detailed description

This study is a randomized controlled trial evaluating whether Sensory Integration Therapy (SIT), when combined with conventional physiotherapy, produces greater improvements in gait symmetry, functional mobility, and balance than conventional physiotherapy alone in children aged 5-12 years with spastic hemiplegic cerebral palsy (CP).

Thirty-two participants will be recruited using non-probability consecutive sampling and then randomly allocated into two equal groups. Group A (experimental) will receive SIT (25 minutes) followed by conventional physiotherapy (20 minutes) per session. Group B (control) will receive conventional physiotherapy alone (45 minutes) per session. Both groups will attend 3 sessions per week for 8 weeks. Treatment content will progress in complexity over four two-week blocks, moving from foundational sensory and mobility activities to advanced, community-level functional tasks.

Outcomes will be assessed using three standardized tools: the Gross Motor Function Measure (GMFM-88), the Pediatric Balance Scale (PBS), and the Edinburgh Visual Gait Score (EVGS), a video-based observational gait analysis tool particularly suited to detecting asymmetry between the affected and unaffected limbs in hemiplegic CP. Assessments will be conducted at baseline and following the intervention period.

This study addresses a gap in the literature, as most prior research on SIT in CP has focused on spastic diplegic subtypes, with comparatively little evidence specific to spastic hemiplegic CP or to gait symmetry as a primary outcome. Data will be analyzed using SPSS, with a mixed-design repeated-measures ANOVA used to evaluate the effects of time, group, and the group-by-time interaction, followed by post hoc analysis where indicated.

Being tested
Sensory Integration Therapy, Conventional Physical Therapy
Keywords
Spastic hemiplegic CP, Gait Symmetry, Functional Mobility, Balance, Conventional Physical Therapy, Edinburg Visual Gait Score, Gross Motor Function Measure, Neurodevelopmental Rehabilitation.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensory Integration TherapyOther

    Also called Conventional physical therapy

    Sensory Integration Therapy (SIT) involved play-based sensory-motor activities targeting tactile, proprioceptive, and vestibular systems, including swinging, weight bearing, and tactile stimulation, progressing to advanced sensory tasks and dual-task training. Provided for 25 minutes per session, followed by 20 minutes of conventional physiotherapy, 3 times per week for 8 weeks.

  • Conventional Physical TherapyOther

    Participants in the control group will receive conventional physiotherapy alone, for 45 minutes per session, 3 times per week, over 8 weeks. Treatment will progress from basic stretching, range of motion exercises, and sitting/standing balance training in the early weeks, to gait training and postural correction by the middle weeks, and finally to advanced balance, endurance, and independent community-level walking practice by the final weeks. Outcomes will be assessed at baseline (Week 0) and post-intervention (Week 9) using EVGS, GMFM-88, and PBS.

Study groups in NCT07733570
Study groupRoleWhat they receive
Experimental Group : SIT Plus ConventionalExperimentalParticipants in this arm will receive Sensory Integration Therapy (SIT) for 25 minutes, followed by conventional physiotherapy for 20 minutes, per session. Sessions will be conducted 3 times per week for 8 weeks. SIT activities will include vestibular stimulation , proprioceptive input and tactile stimulation using varied textures, progressing over the 8 weeks to advanced sensory integration tasks, obstacle navigation, and dual-task training. Conventional physiotherapy will include stretching, range of motion exercises, sitting and standing balance training, sit-to-stand practice, and gait training, progressing to independent walking, task-oriented activities, and community mobility practice.
Receives: Other: Sensory Integration Therapy; Other: Conventional Physical Therapy
Control Group: Conventional Physical TherapyActive comparatorParticipants in this arm will receive conventional physiotherapy only, for 45 minutes per session, 3 times per week for 8 weeks. Treatment will include stretching exercises, range of motion (ROM) exercises, sitting and standing balance training, weight shifting, and reaching activities in the early weeks, progressing to gait training, postural correction exercises, independent standing and walking practice, and functional mobility tasks. By the final weeks, sessions will include advanced gait and balance training, increased endurance activities, and community-level walking practice.
Receives: Other: Conventional Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Edinburgh visual gait score

    EVGS developed by Read and colleagues ,is an observational tool that evaluate gait quality in children with CP across 17 parameters and 6 body segment with score from 0-34 per limb ,where lower scores indicate near normal gait and higher score reflect greater abnormality.. It show Excellent reliability ICC of 0.947(95%) with a Cronbach's alpha value of 0.936,with minimal detectable change of 4.78 to 6.0 points.The EVGS showed good construct validity with a negative correlation with the GMFM-66 (r = -0.50 to -0.70), it also show moderate agreement 52% to 73%, with 3D gait analysis ,supporting criterion validity. In hemiplegic CP, useful for assessing gait symmetry between limbs.The maximum total Score per extermity is 34, the lower then maximum indicate less gait deviation.

    Measured: 8 week

Secondary outcomes (2)
  1. Gross Motor Function Measure -88(GMFM-88)

    The GMFM-88 is an observational gold standard assessment tool used to assess gross motor function in children with CP, It include 88 item/dimension that are divided into 5 areas. Each task is given a score on 4 point scale from 0 to 3,where 0 indicate the child inability to start the task at all and 3 mean the task is fully completed.GMFM-88 is a highly reliable tool with an overall ICC of 0.99 and Intra-rater reliability ranging from with ICC 0.96 and 0.99 across all five areas. Measurement Precision is supported by the SEM of 1.60 and the SRD of 3.14, reflecting stable and trustworthy results in a clinical setting. The tool showed a strong validity ,with high correlation (r = 0.82) with independent clinical judgment and good concurrent validity, with PEDI mobility domain 0.799 to 0.988

    Measured: 8 week

  2. Pediatric Balance Scale (PBS)

    The Pediatric Balance Scale (PBS),adapted from Berg Balance Scale is design to evaluate balance in school-age children with mild to moderate motor impairment. It consist of 14 functional tasks scored on 5 point scale (0 to 4), with maximum score of 56. A higher score means better balance. The Tool show excellent reliability with test -retest ICC = 0.998 and inter-rater reliability ICC = 0.997 in children age 5 to 15 years. Items Level agreement was also strong,( kappa = 0.87 to 1.0). In spastic CP ,the PBS showed high relative reliability with satisfactory absolute reliability based ( SEM and SRD) indicating consistent and reliable results across raters and time. PBS showed a strong concurrent validity with GMFM-88 ( r = 0.926) and with GMFM-66 (r = 0.902) at baseline ,0.89-0.92 at follow up . Additionally a strong and significant co-relation with the mobility section of the PEDI (r = 0.82, p < 0.001)in spastic CP aged 4 to 10y.

    Measured: 8 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2026
  2. Study start22 Aug 2026 (estimated)
  3. Primary completion22 Mar 2027 (estimated)
  4. Study completion20 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07733570
Sponsor's protocol ID
Riphah/RCRAHS-ISB/REC/02575
Status last verified
Jul 2026
First submitted
24 Jul 2026
Last updated
29 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sensory Integration Therapy and Conventional Physical Therapy in people with Spastic Hemiplegic Cerebral Palsy, run by Riphah International University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sidra Ghias Dr.Sidra Ghias, Phd* (03224356227, sidra.ghias@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Edinburgh visual gait score (time frame: 8 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in